TELAPREVIR OR BOCEPREVIR THERAPY IN CHRONIC HEPATITIS C PATIENTS WITH END STAGE RENAL DISEASE ON HEMODIALYSIS IS SAFE, TOLERABLE AND FEASIBLE

被引：3
|
作者：
Sclair, S. [1 ]
Patel, A. [2 ]
Junaidi, O. [3 ]
Copado, V. [3 ]
Martin, P. [1 ]
Rudraraju, M. [3 ]
Bhamidimarri, K. R. [1 ]
机构：
[1] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
[2] San Antonio Mil Med Ctr, Sam Houston, TX USA
[3] Methodist Specialty & Transplant Hosp, San Antonio, TX USA
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)60902-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
900
引用
收藏
页码：S370 / S371
页数：2
相关论文
共 50 条
  • [1] Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir
    Mauss, Stefan
    Eisenbach, Christoph
    Heyne, Renate
    Moog, Gero
    Lutz, Thomas
    Naumann, Uwe
    Geissler, Michael
    Pape, Stefan
    Mordeja, Matthias
    Herold, Christoph
    Simon, Karl-Georg
    Isernhagen, Konrad
    Alshuth, Ulrich
    Buggisch, Peter
    Hueppe, Dietrich
    HEPATOLOGY, 2013, 58 : 1112A - 1112A
  • [2] Renal Impairment Is Frequent in Chronic Hepatitis C Patients Under Triple Therapy With Telaprevir or Boceprevir
    Mauss, Stefan
    Hueppe, Dietrich
    Alshuth, Ulrich
    HEPATOLOGY, 2014, 59 (01) : 46 - 48
  • [3] Renal Impairment Is Frequent in Chronic Hepatitis C Patients Under Triple Therapy With Telaprevir or Boceprevir
    Loustaud-Ratti, Veronique
    Carrier, Paul
    Vong, Chanlina
    Essig, Marie
    HEPATOLOGY, 2014, 59 (06) : 2426 - 2426
  • [4] Renal Impairment Is Frequent in Chronic Hepatitis C Patients Under Triple Therapy With Telaprevir or Boceprevir Reply
    Gordon, Stuart C.
    Yee, Leland J.
    Martins, Eduardo Bruno
    HEPATOLOGY, 2014, 59 (06) : 2427 - 2427
  • [5] Percutaneous liver biopsy in chronic hepatitis C patients with end stage renal disease is safe
    Pawa, S
    Ehrinpreis, MN
    Mutchnick, MG
    Dhar, R
    Siddiqui, FA
    GASTROENTEROLOGY, 2004, 126 (04) : A719 - A719
  • [6] Telaprevir or boceprevir triple therapy in patients with chronic hepatitis C and varying severity of cirrhosis
    Saxena, V.
    Manos, M. M.
    Yee, H. S.
    Catalli, L.
    Wayne, E.
    Murphy, R. C.
    Shvachko, V. A.
    Pauly, M. P.
    Chua, J.
    Monto, A.
    Terrault, N. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (10) : 1213 - 1224
  • [7] Sofosbuvir and Ribavirin is safe and effective therapy in chronic hepatitis C patients with end-stage renal disease on haemodialysis
    Nayak, Sumanlata
    Sharma, Manoj
    Mathur, Rajendra P.
    Varma, Prem Prakash
    Gupta, Ekta
    Choudhary, Ashok
    Jamwal, Kapil D.
    Maiwall, Rakhi
    Kumar, Guresh
    Bhardwaj, Ankit
    Sarin, Shiv K.
    HEPATOLOGY, 2016, 64 : 425A - 425A
  • [8] Percutaneous liver biopsy is safe in chronic hepatitis C patients with end-stage renal disease
    Pawa, Swati
    Ehrinpreis, Murray
    Mutchnick, Milton
    Janisse, James
    Dhar, Ravi
    Siddiqui, Firdous A.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (11) : 1316 - 1320
  • [9] Chronic hepatitis C infection in end stage renal disease - A comparison between chronic hemodialysis patients and renal transplant recipients
    Pol, S
    Benazra, M
    Carnot, F
    Legendre, C
    Nalpas, B
    Mamzer, MF
    Brechot, C
    Kreis, H
    Berthelot, P
    HEPATOLOGY, 1996, 24 (04) : 1070 - 1070
  • [10] Preliminary Experience Of Hepatitis C Genotype 1 Treatment Response With Either Telaprevir Or Boceprevir Based Regimen In Patients With End Stage Renal Disease On Dialysis
    Bhamidimarri, Kalyan R.
    Sclair, Seth N.
    Franco, Melissa
    Patel, Anish
    Copado, Violet
    Junaidi, Omer
    Levy, Cynthia
    Martin, Paul
    Rudraraju, Madhavi
    HEPATOLOGY, 2013, 58 : 1143A - 1143A
12345